A series of 3-descladinosyl-2,3-anhydro-6-O-methylerythromycin A 11,12
-carbamate analogues have been synthesized and evaluated for antibacte
rial activity. These compounds were found to be potent antibacterial a
gents against Gram-positive organisms in vitro, many having MIC values
below 1 mu g/mL for the macrolide-susceptible Staphylococcus aureus,
Streptococcus pyogenes, and Streptococcus pneumoniae, as well as impro
ved activity compared to erythromycin A against the inducibly MLS (mac
rolide, lincosamide, and streptogramin B)-resistant organisms. Structu
re-activity studies revealed that arylalkyl carbamates with two and fo
ur carbon atoms between the aromatic moiety and carbamate nitrogen hav
e the best in vitro activity. All of the C-10 epi analogues evaluated
were found to have substantially less activity than the corresponding
natural C-10 isomer. Several analogues demonstrated moderate antibacte
rial activity against the constitutively resistant S. aureus A-5278, S
. pneumoniae 5979, and S. pyogenes 930. However, despite potent in vit
ro activity, these analogues showed only moderate in vivo activity in
mouse protection studies.